Tmstulsi Medsciences Private Limited
About Tmstulsi Medsciences Private Limited
Data last updated:
Tmstulsi Medsciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24299KA2018PTC112718. Its GSTIN is 29AAGCT7483B1Z2 (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Kamlesh Kumar (Managing Director) and Chanchal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 17/1 Third Floor Berlie Street Shantinagar Bangalore, Karnataka, India – 560027.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.03 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹19.53 Lakh (net margin 1.5%) and EBITDA of ₹39.65 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years and 12% over five years.
The company has about 63 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3 Cr on record.
Company details
Contact details
Tmstulsi Medsciences Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo 17/1 Third Floor Berlie Street Shantinagar Bangalore, Karnataka, India – 560027
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Tmstulsi Medsciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tmstulsi Medsciences is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Tmstulsi Medsciences Private Limited, buy the company report.
Financials of Tmstulsi Medsciences Private Limited
FY 2025 filings availableTmstulsi Medsciences Private Limited reported revenue of ₹13.03 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 33% growth in the latest year. EBITDA rose 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tmstulsi Medsciences Private Limited, buy the company report.
Board of directors of Tmstulsi Medsciences Private Limited
Tmstulsi Medsciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chanchal | Director | 27 Apr 2018 | 8 Years 6 Months | Current |
| Kamlesh Kumar | Managing Director | 27 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Tmstulsi Medsciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sri SPR Biologics Private Limited | ₹13.53 Cr (FY 2024) | -21.0% | Macherla, Andhra Pradesh, India | |||
| Alok Pharmaceutical and Industrial Co Pvt Ltd | ₹13.41 Cr (FY 2025) | -1.0% | Delhi, India | |||
| HK Pharma and Cosmetics Private Limited | ₹13.29 Cr (FY 2025) | -11.0% | Hyderabad, Telangana, India | |||
| Anaga Specialities Private Limited | ₹13.23 Cr (FY 2024) | -37.0% | Mumbai, Maharashtra, India | |||
| Decon Agri Oils Private Limited | ₹13.17 Cr (FY 2024) | -56.0% | Kakinada, Andhra Pradesh, India | |||
| Tmstulsi Medsciences Private Limitedthis company | ₹13.03 Cr (FY 2025) | ₹19.53 Lakh | 1.5% | 33.0% | 63 | Bangalore, Karnataka, India |
| Nalsuvai Agro Food Private Limited | ₹12.59 Cr (FY 2025) | -10.0% | Coimbatore, Tamil Nadu, India | |||
| Toriox Sergusa Packaging Private Limited | ₹12.52 Cr (FY 2025) | 321.0% | Hardwar, Uttarakhand, India | |||
| Sieco Engineers Private Limited | ₹12.17 Cr (FY 2025) | 37.0% | Banglaore, Karnataka, India | |||
| Abone Surgicals Private Limited | ₹12.06 Cr (FY 2025) | 428.0% | Managlore, Karnataka, India | |||
| Lapan Healthcare Private Limited | ₹11.92 Cr (FY 2025) | 34.0% | Panipat, Haryana, India |
To see the full peer comparison of Tmstulsi Medsciences Private Limited, buy the company report.
Auditor
Tmstulsi Medsciences Private Limited is audited by D K S K & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D K S K & ASSOCIATES | FY 2023 | 014950S |
Shareholding
The shareholding of Tmstulsi Medsciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tmstulsi Medsciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2024 | 100904040 | Standard Chartered Bank | ₹1 Cr | Open | |
| 28 Mar 2024 | 100905723 | Standard Chartered Bank | ₹2 Cr | Open |
To see the full charge records of Tmstulsi Medsciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Tmstulsi Medsciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tmstulsi Medsciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Tmstulsi Medsciences Private Limited has a workforce of 63 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Tmstulsi Medsciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCT7483B1Z2 | Karnataka | Active | 31 May 2018 |
To see the full GST registrations and return filing status of Tmstulsi Medsciences Private Limited, buy the company report.
Recent activity
Tmstulsi Medsciences Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Chanchal was appointed as Director on 27 Apr 2018.
Frequently asked questions
Tmstulsi Medsciences is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 April 2018 (8+ years old) and is registered under CIN U24299KA2018PTC112718.
Tmstulsi Medsciences has 2 current directors:
- Kamlesh Kumar - Managing Director
- Chanchal - Director
The latest financial statements of Tmstulsi Medsciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Tmstulsi Medsciences is 29AAGCT7483B1Z2, registered in Karnataka.
The CIN (Corporate Identification Number) of Tmstulsi Medsciences is U24299KA2018PTC112718. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tmstulsi Medsciences was incorporated on 27 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Tmstulsi Medsciences by revenue are Sri SPR Biologics Private Limited, Alok Pharmaceutical and Industrial Co Pvt Ltd, HK Pharma and Cosmetics Private Limited, Anaga Specialities Private Limited, Decon Agri Oils Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Chanchal was appointed as Director on 27 Apr 2018. Kamlesh Kumar was appointed as Managing Director on 27 Apr 2018.
The registered office of Tmstulsi Medsciences is at No 171 Third Floor Berlie Street Shantinagar Bangalore, Karnataka, India – 560027.
Tmstulsi Medsciences operates in the pharma industry, in the drug formulation and development segment.
Tmstulsi Medsciences has open charges of ₹3 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
